Results 281 to 290 of about 425,098 (322)

Emerging gram-positive bacterial infections

Clinics in Laboratory Medicine, 2004
Over the last several decades, a number of previously known or newly described species of gram-positive bacteria have emerged as important human pathogens, particularly in industrialized countries. These microbes have demonstrated an impressive ability to produce an array of striking infectious diseases never before seen or only infrequently ...
Elsayed, Sameer, Laupland, Kevin B.
openaire   +3 more sources

Niclosamide as a repurposing drug against Gram-positive bacterial infections

Journal of Antimicrobial Chemotherapy, 2022
Abstract Objectives Niclosamide is commonly used as an antiparasitic drug in veterinary clinics. The objectives of this study were to evaluate the efficacy of niclosamide against resistant Gram-positive bacteria in vitro and in an in vivo experimental model of topical bacterial infection. Moreover, to
Wei, Zhang, Jinxin, Ran, Lu, Shang, Lifang, Zhang, Mi, Wang, Chenzhong, Fei, Chan, Chen, Feng, Gu, Yingchun, Liu   +8 more
openaire   +2 more sources

Teicoplanin- A New Agent for Gram-Positive Bacterial Infections

Infection Control & Hospital Epidemiology, 1988
Gram-positive bacterial infections remain a serious challenge for infectious disease practitioners. Many gram-positive organisms are developing new methods of antibiotic resistance, thus rendering our standard antimicrobial agents ineffective.
M, Eggleston, J, Ofosu
openaire   +2 more sources

Gram-positive bacterial infection in severe sepsis

Clinical Intensive Care, 2002
They may be involved in the initial insult precipitating an intensive care admission, but are also often acquired as nosocomial pathogens by critically ill patients. Although sepsis in the context of critical illness is a highly complex process often involving polymicrobial infection, 5-8 discussion of Gr am-po sitive sep sis in isolation is not ...
P Hopkins, S Sriskandan
openaire   +1 more source

Therapy of Gram-Positive Bacterial Infections

Veterinary Clinics of North America: Small Animal Practice, 1988
This article considers the important features of gram-positive bacteria that relate to chemotherapy and the clinical pharmacology of the drugs of choice for treating these infections.
openaire   +2 more sources

Nosocomial Gram-positive bacterial infections in children: Results of a 7 year study

Pediatrics International, 2007
AbstractBackground: The aim of the present paper was to determine the rate of culture‐proven nosocomial infections and evaluate the episodes of nosocomial Gram‐positive (GP) bacterial infections in pediatric patients.Methods: The data of children with positive culture, who were diagnosed as having nosocomial infection on the Centers for Disease ...
Cüneyt Özakın
exaly   +4 more sources

Daptomycin Therapy for Invasive Gram-Positive Bacterial Infections in Children

Pediatric Infectious Disease Journal, 2007
Clinical improvement is often delayed among children with invasive infections caused by multidrug resistant Gram-positive bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) despite use of standard antimicrobial therapy.
Monica I, Ardura, Asunción, Mejías, Kathy S, Katz, Paula, Revell, George H, McCracken, Pablo J, Sánchez   +5 more
openaire   +2 more sources

Glycopeptides and Antibiotics for Gram-positive Bacterial Infections

2016
Glycopeptides, lipopeptides and other antibiotics, such as linezolid and quinupristin/dalfopristin , are exclusively used for the treatment of infections caused by Gram-positive bacteria. Limited information is available about the dosing of these antibiotics in obese patients.
Syed Tabish R. Zaidi, Brett Janson
openaire   +1 more source

Polysaccharide Conjugate Vaccines for the Prevention of Gram-Positive Bacterial Infections

1996
Among the most problematic Gram-positive bacteria with regard to human pathology are Staphylococcal species including S. aureus and S. epidermidis, Enterococcal species including E. faecalis and E. faecium, and Streptococcus species including S. pneumoniae and Group B Streptococcus, among others.
R, Naso, A, Fattom
openaire   +2 more sources

Coumarin-modified ruthenium complexes by disrupting bacterial membrane to combat Gram-positive bacterial infection

Dalton Transactions, 2023
Coumarin-modified ruthenium complexes could efficiently disrupt bacterial membrane and cause the death of bacteria.
Hai-Yan Huang, Pei Wang, Wei Deng, Li-Xin Dou, Xiang-Wen Liao, Jin-Tao Wang, Xue-Min Duan, Ru-Jian Yu, Yan-Shi Xiong   +8 more
openaire   +2 more sources